share_log

Today's biggest pre-market stock movers: PTPI, ISPC, QLGN and more

Benzinga Real-time News ·  Nov 23, 2021 07:45  · Movers

Gainers

  • $Petros Pharmaceuticals(PTPI.US)$ rose over 10% in pre-market trading. The company filed a proxy statement for the annual meeting after the market closed on Monday.

  • $iSpecimen(ISPC.US)$ rose 103.8% to $18.10 in pre-market trading. iSpecimen shares jumped more than 80% on Monday after the company announced it has been contracted to support new advanced research on COVID-19 seeking insights on its transmissibility, variants, outcomes, and testing validity among multiple population segments.

  • $Qualigen Therapeutics(QLGN.US)$ rose 93.6% to $2.42 in pre-market trading as traders circulated a Zack's Small Cap research note showing a $9 price target on the stock.

  • $Bit Brother(BTB.US)$ rose 43.5% to $1.23 in pre-market trading after dropping over 12% on Monday.

  • $Allied Esports Entertainment(AESE.US)$ shares rose 15.2% to $2.20 in pre-market trading after the company reported a narrower quarterly loss. The company also highlighted that 'the Company is continuing to identify opportunities to invest the cash on its balance sheet...to acquire or merge with an existing business.'

  • $Quantum-Si(QSI.US)$ rose 11.4% to $7.59 in pre-market trading after dropping 10% on Monday. Quantum-Si recently posted a Q3 loss of $0.13 per share.

  • $RELX PLC(RELX.US)$ rose 11.4% to $5.48 in pre-market trading after climbing 9% on Monday.

  • $Iterum Therapeutics(ITRM.US)$ rose 10.6% to $0.5090 in pre-market trading after declining 7% on Monday. Iterum Therapeutics recently posted Q3 EPS of $0.02.

  • $Longeveron(LGVN.US)$ rose 9.5% to $30.87 in pre-market trading on continued upward momentum after the company last week announced the FDA granted Rare Pediatric Disease designation for Lomecel-B for the treatment of Hypoplastic Left Heart Syndrome.

  • $Tonix Pharmaceuticals(TNXP.US)$ shares rose 9.5% to $0.5095 in pre-market trading. Tonix Pharmaceuticals reported the publication of a paper on antiviral SARS-CoV-2 inhibitor, TNX-3500, in JCI Insight.

  • $Soligenix(SNGX.US)$ rose 7.2% to $0.89 in pre-market trading. Soligenix recently posted a Q3 loss of $0.09 per share.

Losers

  • $Reliance Global Group(RELI.US)$ shares fell 17.5% to $1.74 in pre-market trading. Reliance Global Group promoted Jonathan Fortman to Vice President of Acquisitions.

  • $BioHiTech Global(BHTG.US)$ fell 15.3% to $0.80 in pre-market trading after declining 8% on Monday. BioHiTech Global, last week, said Q3 EPS and sales results were higher year over year.

  • $Adamis Pharmaceuticals(ADMP.US)$ fell 13.8% to $0.7590 in pre-market trading. Adamis Pharmaceuticals said sales for the nine months ended Sept. 30, 2021 came in at $3.4 million.

  • $Urban Outfitters(URBN.US)$ fell 13.3% to $32.32 in pre-market trading. Urban Outfitters posted upbeat earnings and sales results for the third quarter. Its same-store sales climbed 14.6% year-over-year during the quarter.

  • $PainReform(PRFX.US)$ fell 12.5% to $2.01 in pre-market trading. PainReform recently posted a net loss of $5.5 million during the nine months ended Sept. 30, 2021.

  • $iPower(IPW.US)$ shares fell 9% to $2.74 in pre-market trading after dropping over 9% on Monday. iPower recently entered into $25 million credit facility with JPMorgan Chase.

  • $Zoom Video Communications(ZM.US)$ fell 8.7% to $221.19 in pre-market trading. Zoom Video reported better-than-expected results for its third quarter on Monday. The company reported its customers that contribute more than $100,000 in the trailing 12 months totaled 2,507, up 94% year-over-year.

  • $Progenity(PROG.US)$ shares fell 8.3% to $4.08 in pre-market trading following a 9% decline in the previous session.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment